open access

Vol 5, No 3 (2004): Practical Diabetology
Other materials agreed with the Editors
Published online: 2004-05-20
Get Citation

Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting

Sarah J. Beaton, Soma S. Nag, Margaret J. Gunter, Jeremy M. Gleeson, Shiva S. Sajjan, Charles M. Alexander
Diabetologia Praktyczna 2004;5(3):147-153.

open access

Vol 5, No 3 (2004): Practical Diabetology
Original articles (translated)
Published online: 2004-05-20

Abstract

INTRODUCTION. We conducted a retrospective study to evaluate the adequacy of glycemic, lipid, and blood pressure (BP) management for diabetic patients in a managed care organization (MCO).
MATERIAL AND METHODS. Patients aged ≥ 18 years with diabetes (n = 7,114) were retrospectively identified over a 2-year period from the MCO’s administrative database based on the Health Plan Employer Data and Information Set 2000 selection criteria using pharmacy, laboratory, and encounter data. Analyses examined demographics and percentages of patients tested and meeting American Diabetes Association goals for HbA1c, lipids, and BP, both overall and for those receiving medication treatment versus no treatment.
RESULTS. Testing rates for A1C, LDL cholesterol, and BP were 77, 54, and 95%, respectively. The percentage of patients tested who were at goal were 37% for A1C, 23% for LDL cholesterol, and 41% for systolic BP. Of the patients in our sample, 72% were treated for glycemic control, 64% were treated for BP control, and only 28% were treated for lipid control. Of the patients who received medication treatment, less than one-third were at goal for A1C (29%) and LDL cholesterol (32%), whereas 40% were at goal for systolic BP.
CONCLUSIONS. We found that although a large percentage of diabetic patients were tested for A1C, LDL cholesterol, and systolic BP, a much smaller percentage had reached their respective goals. More aggressive glycemic, lipid, and BP management appears to be needed to improve care for these patients.

Abstract

INTRODUCTION. We conducted a retrospective study to evaluate the adequacy of glycemic, lipid, and blood pressure (BP) management for diabetic patients in a managed care organization (MCO).
MATERIAL AND METHODS. Patients aged ≥ 18 years with diabetes (n = 7,114) were retrospectively identified over a 2-year period from the MCO’s administrative database based on the Health Plan Employer Data and Information Set 2000 selection criteria using pharmacy, laboratory, and encounter data. Analyses examined demographics and percentages of patients tested and meeting American Diabetes Association goals for HbA1c, lipids, and BP, both overall and for those receiving medication treatment versus no treatment.
RESULTS. Testing rates for A1C, LDL cholesterol, and BP were 77, 54, and 95%, respectively. The percentage of patients tested who were at goal were 37% for A1C, 23% for LDL cholesterol, and 41% for systolic BP. Of the patients in our sample, 72% were treated for glycemic control, 64% were treated for BP control, and only 28% were treated for lipid control. Of the patients who received medication treatment, less than one-third were at goal for A1C (29%) and LDL cholesterol (32%), whereas 40% were at goal for systolic BP.
CONCLUSIONS. We found that although a large percentage of diabetic patients were tested for A1C, LDL cholesterol, and systolic BP, a much smaller percentage had reached their respective goals. More aggressive glycemic, lipid, and BP management appears to be needed to improve care for these patients.
Get Citation

Keywords

diabetes; glycemic control; blood pressure; lipids

About this article
Title

Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting

Journal

Clinical Diabetology

Issue

Vol 5, No 3 (2004): Practical Diabetology

Article type

Other materials agreed with the Editors

Pages

147-153

Published online

2004-05-20

Bibliographic record

Diabetologia Praktyczna 2004;5(3):147-153.

Keywords

diabetes
glycemic control
blood pressure
lipids

Authors

Sarah J. Beaton
Soma S. Nag
Margaret J. Gunter
Jeremy M. Gleeson
Shiva S. Sajjan
Charles M. Alexander

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl